Technology is beginning to offer the ability to identify, connect and assist patients from even the most remote locations in the world
This webinar will explore the patient's perspective on the barriers to patient engagement in the clinical trials. We discuss the clinical trials of the future in a world of cognitive computing and predicative analytics and how to engage patients further. It also provides a pharma and CRO view on issues to produce more engaging, cost- effective clinical trials.
Chief Information Officer at ICON
Tom is ICON's Chief Information officer previous to this he held the position of President of ICON Central Laboratories. He joined the company in Feb-2001 as Manager of Data management in Dublin, he subsequently went on to set-up ICON's process improvement initiative "IMPROVE" and returned to Data Management to become EU VP of Data Management before becoming Global Head of Data Management in 2006. He is a graduate of Kingston University in Surrey and a Member of the Royal Society of Chemistry. He holds a Degree in Medicinal Chemistry and a Masters in Data Management.
- Jamie Goldfarb, Cancer Survivor and Patient Advocate
- Dr. Anil Jain, SVP & Chief Medical Officer
- Dr. Jason Gilder, Senior Director of Analytics & Informatics at Explorys (an IBM company)
- Tammy Guld, Head of Clinical Trial Planning and Operations at Bristol-Myers Squibb
- The patient's perspective on clinical trials with Jamie Goldfarb, Cancer Survivor and Patient Advocate
- Utilization of data and analytics by Dr. Anil Jain, SVP & Chief Medical Officer and Dr. Jason Gilder, Senior Director of Analytics & Informatics at Explorys (an IBM company)
- Digital patient of the future by Tom O'Leary, Chief Information Officer at ICON
- Planning with Pharma by Tammy Guld, Head of Clinical Trial Planning and Operations at Bristol-Myers Squibb
- Questions & Answers
This webinar is intended for anyone interested or involved in clinical trials and digital health, for instance, clinicians, patients, big data specialists, pharma and CRO representatives.